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Abstract. A total of 66 fecal specimens obtained from patients infected with human immunodeficiency virus
(HIV) from Kajang Hospital were screened for Cryptosporidium oocysts. The fecal specimens were concentrated
using the formalin ethyl acetate concentration technique, stained with modified Ziehl-Neelsen and confirmed
with immunofluorescence stain. It was established that 2 (3.0%) were positive for Cryptosporidium. The two
cases involved a Chinese local man (with diarrhea) and an Indonesian foreigner (without diarrhea). A higher
index of suspicion for clinical cryptosporidiosis in HIV patients, including those with chronic weight loss with or
without diarrhea, is recommended. In addition, laboratory testing for Cryptosporidium in HIV-infected patients
is highly recommended in order to have a better understanding of the epidemiology and management of the
disease in Malaysia.
susceptible, comprise only a minority of the large
number of parasites capable of causing human disease.
Intestinal parasites that have exploited the
immunological defect in HIV infected patients include
Cryptosporidium species (Zumla and Crofts, 1992).
Cryptosporidium, a small, obligate intracellular
parasite, has emerged as an important cause of chronic
life-threatening diarrhea (Das et al, 1993), causing
prolonged and cholera-like diarrhea in HIV infected
patients (Petersen, 1992). However, in immuno-
competent persons, it may cause a short-term diarrheal
illness that resolves spontaneously. The route of
transmission has been associated with fecal-oral, as
well as through drinking contaminated water, person-
to-person spread and contact with infected animals (Ng
and Shekhar, 1993; Morgan and Thompson, 1998).
A prospective long-term study from Europe
suggested that 3-4% of those with HIV will have
cryptosporidiosis and that an equal number will
develop it later in the course of their disease (Pedersen
et al, 1996). However, this parasite has been identified
in up to 46% of HIV patients world-wide in other
studies (Bonilla et al, 1992).
In Malaysia, the problem of cryptosporidiosis
among HIV patients has not received much attention,
as evidenced by the lack of reports. This could possibly
be due to underdiagnosis of the disease, or patients
being screened only when they reach the AIDS stage
with chronic, persistent diarrhea or when symptomatic
treatment fails. Another contributing factor could be a
lack of emphasis on this diagnosis, as there remains
no specific cure for the disease apart from antiretroviral
therapy. The first reported study among HIV positive
intravenous drug users (IVDU) in Malaysia was
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INTRODUCTION
Over the past decade, the role of Cryptosporidium
as an agent of human diarrhea has been redefined from
that of a rare opportunist to a pathogen with worldwide
distribution and the potential for significant morbidity
and mortality. Lately, the strong association between
cases of cryptosporidiosis and immunodeficient
individuals (such as those with AIDS) brought
Cryptosporidium to the forefront as an ubiquitous
human pathogen (Smith et al, 1998).
Presently, the increasing population of immu-
nocompromized persons and various outbreaks through
infection by waterborne Cryptosporidium oocysts
(often in drinking water) have placed an even greater
emphasis on this pathogen. To date, there is no proven
effective drug therapy for this parasite, and, in part
due to its inability to grow well in vitro, the human
immune response to cryptosporidial infection remains
poorly understood.
The spread of human immunodeficiency virus
(HIV) infection in Malaysia has risen significantly
since the early 1980s. As of 31st December 2001, the
Ministry of Health Malaysia reported that there were
44,272 cases of HIV infections in Malaysia with an
average of 5,000 new infections detected per year
(Ministry of Health, Malaysia, 2002). Opportunistic
infections, to which HIV infected patients are
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conducted in 1994 indicating high prevalence (23%)
of cryptosporidiosis (Kamel et al, 1994). Since then
there has not been any other report.
The aim of this present study is to determine the
prevalence of cryptosporidiosis among HIV infected
patients in a hospital setting. The findings will
hopefully lead to better understanding and management
of cryptosporidiosis in HIV infected patients in
Malaysia.
MATERIALS AND METHODS
A total of 66 HIV infected patients from Kajang
Hospital, Selangor were included in this study. A single
stool specimen was collected from each patient
between April and July 2004. The consistency of the
stool specimens was graded by categories (soft, watery,
etc) while waiting to be processed.
Stool specimens were concentrated using the
formalin-ethyl acetate concentration technique and
stained with modified Ziehl-Neelsen (acid-fast stain).
Slides were examined under 400x.  Cryptosporidium
oocysts appeared as bright rose-pink spheres (5 + 1 μm)
on a pale green background. All slides positive for
Cryptosporidium using the Ziehl-Neelsen staining
method were recorded.
The presence of Cryptosporidium oocysts in the
positive specimens were then confirmed using the
immunofluorescence technique, which is more specific
and sensitive. In the immunofluorescence technique,
specimens were stained with the commercially available
fluorescein isothiocynate (FITC)-labeled anti-
Cryptosporidium oocysts mAb (Crypto-a-Glo kit,
Waterborne, Inc, New Orleans, USA), which stains the
oocyst wall bright apple green and 4´, 6-diamidino-2-
phenylindole (DAPI) stain (Sigma Chemical, Missouri,
USA), which stains the four nuclei sky-blue. Slides were
viewed under 400x epifluorescence microscope
(Olympus BX52, Japan) with wide band excitation color
separation filter (exciter 460-490 nm, barrier 550 nm)
to detect FITC stain, a wide band UV filter (exciter 330-
335 nm, barrier 420 nm) for DAPI stain and Nomarski-
DIC optics to observe the internal structures of
Cryptosporidium oocyst (about 4 to 6μm in diameter).
Positive control slides containing oocysts and negative
control slides were included in the analysis.
RESULTS
A total of 66 stool specimens were obtained from
HIV infected patients admitted to Kajang Hospital. The
range of patients’ ages was 29-56 years. They consisted
of 59 (89.4%) males and 7 (10.6%) females. Their
various ethnicities were: Malay (47; 71.2%), Chinese
(9; 13.6%), Indian (8; 12.1%), and others (2; 3%). Only
6 (9.1%) of the stool specimens were watery, while
soft and hard stool forms were 31 (47%) and 29
(43.9%), respectively.
Out of 66 stool specimens screened for
Cryptosporidium oocysts, only 2 (3.03%) were positive
for cryptosporidiosis. The profiles of the two positive
patients with cryptosporidiosis were as follows:
Case 1
LKH was a 37-year old Chinese man who was
admitted into Kajang Hospital in a very ill state. He
was known to have HIV but was not on any
antiretroviral therapy. His baseline CD4 counts were
unknown. He was also known to have pulmonary
tuberculosis(TB) and was on anti-TB medications.
Examination revealed a weak, cachectic, dehydrated
and hypotensive patient. While in the ward, he was
noted to have diarrhea. Laboratory diagnosis later
detected Cryptosporidium oocysts in his stool sample
with a concentration of 1.1x106 oocysts per gram.
Unfortunately the patient succumbed to his illness 36
hours after admission.
Case 2
SS is a 29-year old Indonesian man. He was known
to have HIV infection but was not on antiretroviral
therapy. His CD4 count was 37 cells/mm3. He also
had pulmonary TB and was on anti-TB medications.
He presented with a one-month history of reduced oral
intake, reduced appetite and vomiting. He did not have
diarrhea. He was cachectic, weak, dehydrated and had
a low grade fever. He also had oral cavity ulcers which
healed with treatment. Laboratory diagnosis later
detected Cryptosporidium oocysts in his stool with a
concentration of 3.6x106 oocysts per gram. He has
since been deported back to Indonesia.
DISCUSSION
The prevalence of cryptosporidiosis in Malaysian
HIV-infected hospital patients as revealed in this study
was 3.03%. This finding is similar with the results
obtained by Sorvillo et al (1994) and Pedersen et al
(1996), who reported 3-4% of those with HIV have
cryptosporidiosis. Epidemiological surveys carried out
in various parts of the world revealed that the
prevalence rate of cryptosporidiosis was anywhere
from 3-50% (Bonilla et al, 1992; Pedersen et al, 1996).
A number of studies indicated that the prevalence of
cryptosporidiosis in HIV-infected patients was in the
range of 15% or below (Florez et al, 2003).
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In Brazil, the occurrence of Cryptosporidium
infection in 52 HIV/AIDS patients was found to be 5.8%
using safranin/methylene blue, modified trichrome
staining techniques and enzyme immunoassay (EIA)
(Silva et al, 2003). In another study, also in Brazil, 9.33%
of samples were positive for Cryptosporidium, with
higher frequency of cases in male patients from 20 to
50 years old (Ribeiro et al, 2004).
A study among 156 HIV-infected Thai patients who
had acute diarrheal illness showed that 12.8% had
cryptosporidiosis (10.0% in males and 19.1% in
females) (Saksirisampant et al, 2002). However, in
Nigeria, a study carried out on 161 HIV-infected
patients with chronic diarrhea revealed no
cryptosporidium oocysts or any other acid-fast
organism in stool. It was concluded that intestinal
cryptosporidiosis is not common in HIV-infected
patients with chronic diarrhea in Enugu. Nonetheless,
more studies are needed to further confirm this trend
(Nwokediuko et al, 2002).
The two patients with cryptosporidiosis in this
study had differing presentations. The first had classical
symptoms of severe diarrhea to a point where he was
severely dehydrated and cachectic by the time he was
admitted. In fact, cryptosporidiosis was likely to be
the cause of his demise.
The importance of Cryptosporidium as a
widespread cause of diarrhea is well recognized.
Reported prevalence of cryptosporidiosis associated
with diarrhea in Asia ranged from 3.2% in Thailand,
3.6% in China, 10.0% in Indonesia and 13.3% in India
(Katsumata et al, 1998). A study in patients with HIV
infection in South Italy showed that 21.5% of patients
with diarrhea and 3.4% of patients without diarrhea
had cryptosporidiosis. A significant (p<0.001)
correlation was observed between Cryptosporidium
infection and the presence of diarrhea (Brandonisio et
al, 1999).
The second patient in this study had a subclinical
presentation. The symptoms of loss of appetite, reduced
oral intake, weight loss, vomiting, and low grade
temperature may well have been due to crypto-
sporidiosis, but there was no history of chronic
diarrhea. His CD4 count was also very low (37 cells/
mm
3). Flanigan et al (1992) reported that 87% of
patients with CD4 counts of less than 140 cells/mm3
who have cryptosporidiosis will develop persistent
disease. Unfortunately, the progress of this patient
could not be tracked since he was deported back to his
homeland, Indonesia.
Occurrence of asymptomatic (no signs of diarrhea)
carriers of Cryptosporidium in HIV patients was not
surprising. High occurrences (23%) of Crypto-
sporidium in asymptomatic HIV positive IVDU drug
users have been reported by Kamel et al (1994). Ravn
et al (1991) also found the occurrence of asymptomatic
carriers of Cryptosporidium to be common among
AIDS patients. The presence of Cryptosporidium
oocysts in asymptomatic patients noteworthy because
they can act as important reservoirs for the organism
and might be a potential source of infection.
In Malaysian hospitals, HIV infected patients are
normally worked up for cryptosporidiosis when the
CD4 levels are low and the patients present with
chronic, persistent diarrhea. It would be advisable to
recognize that cryptosporidiosis can present with just
chronic weight loss and other nonspecific symptoms
devoid of diarrhea. Hence, a higher index of suspicion
for clinical cryptosporidiosis in HIV patients, including
those with chronic weight loss with or without diarrhea,
is recommended. Additionally, laboratory testing for
Cryptosporidium in HIV infected patients is highly
recommended in order to have a better understanding
of the epidemiology and management of the disease
in Malaysia.
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